CHUCOTC

Charlie's Holdings, Inc.

Consumer Defensive·Pain·Costa Mesa, CA, United States
PainPsychiatry

Charlie's Holdings, Inc. (CHUC): 33 pipeline candidates. Updated within the last hour.

8.3/10

BioSniper Score

3-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health5.0

D/E 3.78 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

33 candidates

Catalyst MomentumN/A

N/A

Insider Signal10.0

6 buys · 0 sells (180d)

A transparent, data-derived signal for Charlie's Holdings, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$62.0M

Cash

Quarterly Burn

$1.1M

Runway

Revenue

$4.8M

Pipeline (33 candidates)

Showing 10 of 33 candidates. Sign up for full pipeline.

·CEO: Chief Executive Officer

Frequently asked questions

How many drug candidates are in Charlie's Holdings, Inc.'s pipeline?

Charlie's Holdings, Inc. (CHUC) has 33 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Charlie's Holdings, Inc.'s market capitalization?

Charlie's Holdings, Inc.'s market capitalization is approximately $62.0M.

Who is the CEO of Charlie's Holdings, Inc.?

Chief Executive Officer is the chief executive officer of Charlie's Holdings, Inc. (CHUC).

Get the full picture on Charlie's Holdings, Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.